Telomir Pharmaceuticals, Inc. Common Stock (TELO) Stock Forecast & Price Target
Telomir Pharmaceuticals, Inc. Common Stock · NASDAQ
$1.23+0.08 (+6.96%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for TELO yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $1.23 current
Highest Target—
Average Target—
Lowest Target—
Top analysts covering Telomir Pharmaceuticals, Inc. Common Stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TELO.
#1
MK
Michael King
Rodman & Renshaw
Buy
$8.00+550.4% to target
Coverage
—
+ Follow
TELO stock forecast FAQ
Who is the most accurate analyst covering TELO?+
Among analysts who currently cover TELO, Michael King of Rodman & Renshaw has the strongest overall Quantellect track record. Their current call is Buy with a $8.00 target.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TELO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
